The Prevalence of Low-level Viraemia and Its Association with Virological Failure in People Living With HIV: A Systematic Review and Meta-Analysis
S Zhao, W Wang, S Li, J He, W Duan… - Emerging Microbes & …, 2024 - Taylor & Francis
Low-level viraemia (LLV) following antiretroviral therapy (ART) in people living with HIV
(PLWH) has not received sufficient attention. To the determine the prevalence of LLV and its …
(PLWH) has not received sufficient attention. To the determine the prevalence of LLV and its …
Temporal dynamics and drivers of durable HIV viral load suppression and persistent high‐and low‐level viraemia during Universal Test and Treat scale‐up in Uganda …
Introduction Population‐level data on durable HIV viral load suppression (VLS) following the
implementation of Universal Test and Treat (UTT) in Africa are limited. We assessed trends …
implementation of Universal Test and Treat (UTT) in Africa are limited. We assessed trends …
Longitudinal viral load outcomes of adults with HIV after detectable viremia on tenofovir, lamivudine, and dolutegravir
O Sodeke, K Milligan, I Ezeuko, A Oladipo, A Emeh… - AIDS, 2024 - journals.lww.com
Background: To inform optimal management of HIV viremia on tenofovir, lamivudine, and
dolutegravir (TLD), we examined viral load (VL) outcomes of a large cohort of adult PWH on …
dolutegravir (TLD), we examined viral load (VL) outcomes of a large cohort of adult PWH on …
The virological consequences of low-level viraemia
BO Olakunde, EE Ezeanolue - The Lancet Global Health, 2022 - thelancet.com
With highly active antiretroviral therapy (ART), people living with HIV can achieve and
maintain viral suppression below a detectable level, preventing transmission of HIV and …
maintain viral suppression below a detectable level, preventing transmission of HIV and …
Detectable Virological Load and Associated Factors among People Living with HIV on Antiretroviral Treatment: A Retrospective Study
P Congedo, R Sedile, M Guido, F Banchelli, A Zizza - Pathogens, 2024 - mdpi.com
The complete and prolonged suppression of viral load is the primary objective of HAART in
people living with HIV. Some people may experience therapeutic failure, while others may …
people living with HIV. Some people may experience therapeutic failure, while others may …
Incidence of low-level viremia and its impact on virologic failure among people living with HIV who started an integrase strand transfer inhibitors: a longitudinal cohort …
X Lao, H Zhang, M Deng, Q Li, Q Xiao, L He… - BMC Infectious …, 2024 - Springer
Background Low-level viremia (LLV) has been identified as a potential precursor to virologic
failure (VF), yet its clinical implications, particularly within the context of Integrase Strand …
failure (VF), yet its clinical implications, particularly within the context of Integrase Strand …
Prevalence and predictors of persistent low-level HIV viraemia: a retrospective cohort study among people receiving dolutegravir-based antiretroviral therapy in …
Background: Persistent low-level viraemia (PLLV) is a risk factor for virologic failure among
people receiving antiretroviral therapy (ART). Objectives: We assessed the prevalence and …
people receiving antiretroviral therapy (ART). Objectives: We assessed the prevalence and …
Low-Level Viremia among Adults Living with HIV on Dolutegravir-Based First-Line Antiretroviral Therapy Is a Predictor of Virological Failure in Botswana
OT Bareng, S Moyo, M Mudanga, K Sebina… - Viruses, 2024 - mdpi.com
We evaluated subsequent virologic outcomes in individuals experiencing low-level virem ia
(LLV) on dolutegravir (DTG)-based first-line antiretroviral therapy (ART) in Botswana. We …
(LLV) on dolutegravir (DTG)-based first-line antiretroviral therapy (ART) in Botswana. We …
HIV risk behaviour, viraemia, and transmission across HIV cascade stages including low-level viremia: Analysis of 14 cross-sectional population-based HIV Impact …
O Edun, L Okell, H Chun, ACZ Bissek… - PLOS Global Public …, 2024 - journals.plos.org
As antiretroviral treatment (ART) coverage for people living with HIV (PLHIV) increases, HIV
programmes require up-to-date information about evolving HIV risk behaviour and …
programmes require up-to-date information about evolving HIV risk behaviour and …
Prevalence of HIV drug resistance among adolescents receiving ART in Cameroon with low-or high-level viraemia
ABD Djiyou, CI Penda, Y Madec… - Journal of …, 2023 - academic.oup.com
Objectives To characterize HIV drug resistance (HIVDR) below and above the WHO
threshold of 1000 copies/mL, considered for the definition of HIV ART failure in resource …
threshold of 1000 copies/mL, considered for the definition of HIV ART failure in resource …